Subscribe

Miloš Miljković, MD

Articles by Miloš Miljković, MD

Miloš Miljković, MD, chief medical officer, Cartesian Therapeutics

mRNA-CAR-T Descartes-08's Potential for Treating Myasthenia Gravis

ByMiloš Miljković, MD,Noah Stansfield

September 6th 2024

Miloš Miljković, MD, the chief medical officer of Cartesian Therapeutics, discussed data presented at ASGCT 2024 from a phase 2a study.

Miloš Miljković, MD, on mRNA-CAR-T Descartes-08's Potential for Treating Myasthenia Gravis

Miloš Miljković, MD, on mRNA-CAR-T Descartes-08's Potential for Treating Myasthenia Gravis

ByMiloš Miljković, MD,Victoria Johnson

July 22nd 2024

The chief medical officer of Cartesian Therapeutics discussed data presented at ASGCT 2024 from a phase 2a study.

Latest Updated Articles

Trending on CGTlive®

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

CGTLive®’s Weekly Rewind – October 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.